Plexus Ventures to Assist GlaxoSmithKline Consumer Healthcare with Regional Acquisitions    more...... ________________________________________________________________________________________

PLEXUS VENTURES was formed in 1990 to offer consulting services to the Life Sciences industry.  Our vision is to provide a global network of professional consultants to augment the internal capabilities of Life Science companies.   Our team consists of pharmaceutical industry trained and experienced entrepreneurs who assist our clients by:

• Expanding in-house Business Development capabilities, with particular emphasis on the in-licensing, out-licensing, acquisition or divestiture of products, compounds and technologies;
• Providing Strategic Advice to meet challenges posed by competition and uncertainty;
• Assessing and improving Alliance Management capabilities;
• Evaluating new business opportunities;
• Offering independent assessment of the potential value of new products or technologies; and
• Identifying, evaluating and negotiating merger and acquisition opportunities.
• In recent years, Plexus Ventures has assisted its clients to conclude transactions valued at more than $1 billion. 

PLEXUS VENTURES has successfully completed deals with 7 of the top 10 global pharmaceutical companies including Novartis, Pfizer, Merck, Sanofi-Aventis, Johnson & Johnson, Bristol-Myers Squibb and AstraZeneca.